Xi, Zheng-Xiong <br/><br/>
Hypothesis-driven medication discovery for the treatment of psychostimulant addiction.  [electronic resource] 

 -  Current drug abuse reviews  Nov 2008 
 - 303-27 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Intramural; Review 
<br/><br/><label>ISSN: </label>1874-4745 
<br/><br/><label>Standard No.: </label>10.2174/1874473710801030303  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Brain--drug effects<br/>Cannabinoid Receptor Modulators--metabolism<br/>Central Nervous System Stimulants<br/>Cocaine-Related Disorders--diagnosis<br/>Dopamine--metabolism<br/>Dopamine Agonists--adverse effects<br/>Dopamine Antagonists--adverse effects<br/>Drug Evaluation, Preclinical<br/>Excitatory Amino Acid Agonists--adverse effects<br/>GABA Agonists--adverse effects<br/>GABA Uptake Inhibitors<br/>Glutamic Acid--metabolism<br/>Humans<br/>Narcotic Antagonists--adverse effects<br/>Receptors, AMPA--antagonists & inhibitors<br/>Receptors, N-Methyl-D-Aspartate--antagonists & inhibitors<br/>Serotonin Antagonists--adverse effects<br/>Serotonin Receptor Agonists<br/>Substance-Related Disorders--diagnosis<br/>Treatment Outcome<br/>Vesicular Monoamine Transport Proteins--antagonists & inhibitors<br/>gamma-Aminobutyric Acid--metabolism